Akcea Therapeutics, Inc. announced that Christophe Hotermans, M.D., Ph.D., has joined the company as senior vice president of global medical affairs where he will lead and evolve the execution of medical strategies, activities and operations worldwide in collaboration with executive management. Prior to joining the company, Dr. Hotermans' served at Biogen for more than a decade in various roles, most recently as vice president and head of U.S. medical, where he was responsible for the U.S. medical strategy and execution across all therapeutic areas, including multiple sclerosis, Alzheimer's disease, movement disorders and amyotrophic lateral sclerosis.